SECTOR ANALYSIS

Sleep Rare Disease Biotech Companies

Grades, scores, and FDA catalyst signals for Sleep Rare Disease stocks tracked by BiotechSigns

← Full Screener FDA Calendar All Sectors

Companies

Avg Score

Top Grade

Grade A

Sleep Rare Disease Companies— 6 tracked

Ticker	Company	Score	Grade	Sector	Signals
AGIO	Agios Pharmaceuticals	86	A	Rare Disease	—
RETA	Reata Pharmaceuticals	64	C	Rare Disease	—
RARE	Ultragenyx Pharmaceutical	63	C	Rare Disease	—
FOLD	Amicus Therapeutics	62	C	Rare Disease	—
STOK	Stoke Therapeutics	50	D	Rare Disease	—
OVID	Ovid Therapeutics	45	D	Rare Disease	—

Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSigns grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.